Type 2 diabetes and obesity in adults

British Journal of Nursing

Volumn 19, Issue 14, 2010, Pages 880-886

  Whitmore, Catherine ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Obesity; Overweight; Type 2 diabetes; Weight reduction

Indexed keywords

ANTIDIABETIC AGENT; ANTIOBESITY AGENT;

ABDOMINAL OBESITY; ADULT; ARTICLE; BARIATRIC SURGERY; FEEDING BEHAVIOR; HUMAN; INSULIN RESISTANCE; LIFESTYLE; LOW CALORY DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE ATTITUDE; OBESITY; PATIENT EDUCATION; RISK FACTOR; UNITED KINGDOM;

ADULT; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FOOD HABITS; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIFE STYLE; NURSE'S ROLE; OBESITY; OBESITY, ABDOMINAL; PATIENT EDUCATION AS TOPIC; RISK FACTORS;

EID: 77956223799     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.14.49041     Document Type: Article

References (43)

1. Arora S, MacFarlene SI (2005) The case for low carbohydrate diets in diabetes management. Nutr Metab 2: 16
2. Bagg W, Plank LD, Gamble G, Drury PL, Sharpe N, Braatvedt GD (2001) The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes Obes metab 3(6): 410-416 (Pubitemid 34030859)
3. Bailey C, Gross J, Pieters A, Bastien A, List J (2010) Effect of Dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 375: 2223-2233
4. Balkau B, Deanfield J,E Després J et al (2007) International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116(17): 1942-1951
5. Ball K, Crawford D, Owen N (2000) Obesity as a barrier to physical activity. Aust N Z J Public Health 24(3): 331-333
6. Bays H, Mandarino L, DeFronzo R (2004) Role of the adipocyte, free fatty acids and ectopic fat in the pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonsists provide a rational thereputic approach. J Clin Endocrinol Metab 89(2): 463-478
7. Berne C (2005) A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin. Diabet Med 22(5): 612-618
8. Brinkworth GD, Noakes M Parker B, Foster P. Clifton PM (2004) Long-term effects of advice to consume a highprotein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with Type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia 47(10): 1677-1686
9. Buchwald H, Estok R, Fahrbach K et al (2009) Weight and Type 2 diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. Am J Med 122(3): 248-256
10. Buse JB, Henry RR, Han J et al (2004) Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes. Diabetes Care 27(11): 2628-2635
11. Buse J, Rosenstock J, Sesti G et al (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374(9683): 39-47
12. Carey VJ, Walters EE, Colditz GA et al (1997) Body fat distribution and Risk of Non-Insulin-dependent Diabetes Mellitus in Women: The Nurses' Health Study. Am J Epidemiol 145(7): 614-619
13. Chen M, Roberts A (2009) Special considerations in managing obesity. In: Williams G, Frühbeck G. eds, Obesity: Science to Practice. Wiley-Blackwell, West Sussex
14. Chipkin S, Goldberg R (2009) Obesity surgery and diabetes: does a chance to cut mean a chance to cure? Am J Med 122(3): 205-206
15. Dewan S, Wilding J (2005) Adult obesity: Metabolic syndrome, diabetes and non-alcoholic steatohepatitis. In: Kopelman P, Caterson I, Dietz W. eds, Clinical Obesity in adults and children. 2nd edn. Blackwell Publishing, Oxford
16. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD (2005) Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformintreated patients with type 2 diabetes. Diabetes Care 28(5): 1092-1100
17. Diabetes UK (2008) Background on the campaign. http://tinyurl.com/ 385bp3b(accessed 14 July 2010)
18. Diabetes UK (2009) Managing your Weight. http://tinyurl.com/25lrf9d (accessed 9July 2010)
19. Diabetes UK (2010) What is Diabetes? http://tinyurl.com/2a4ngu7 (accessed 9 July s2010)
20. Gannon MC, Nuttall FQ (2004) Effect of a high-protein, lowcarbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53(9): 2375-2382
21. Genentech USA Inc (2010) Xenical: Mechanisms of action. www.xenical.com/hcp/3-moa.asp (accessed on 9 July 2010)
22. Gutierrez M, Akhavan M, Jovanovic L, Peterson C (1998) Utility of a short-term 25% carbohydrate diet on improving glycemic control in type 2 diabetes mellitus. J Am Coll Nutr 7(6): 595-600
23. Hollander P (2007) Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People With Diabetes. Diabetes Spectr 20(3): 159-165
24. Hollander P, Elbein S, Hirsch I et al (1998) Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 21: 1288-1294
25. Kelley D, Bray G, Pi-Sunyer F et al (2002) Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: A 1-year randomized controlled trial. Diabetes Care 25: 1033-1041
26. Klein S, Sheard N, Sunyer X et al (2004) Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care 27: 2067-2073 (Pubitemid 38989258)
27. Kushner R (2002) Very Low Calorie Diets. In: Bessesen D, Kushner R. eds, Evaluation and Management of Obesity. Hanley & Belfus, Philedephia
28. Langin D, Frühbeck G, Frayn K, Lafontan M (2009) Adipose tissue: development, anatomy and functions. In: Williams G, Frühbeck G. eds, Obesity: Science to Practice. Wiley-Blackwell, West Sussex
29. Ma R, Chan J (2009) Obesity and the development of type 2 diabetes. In: Williams G, Frühbeck G. eds, Obesity: Science to Practice. Wiley-Blackwell, West Sussex
30. Marre M, Shaw J, Brändlem M et al (2009) Liraglutide, a oncedaily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type2 diabetes (LEAD-1 SU). Diabetic Medicine 26(3): 268-278
31. Nauck M, Frid A, Hermansen K et al (2009)Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study. Diabetes Care 32: 84-90
32. National Institute for Health and Clinical Excellence (2008) Type 2 diabetes: full guidance. http://tinyurl.com/34pjdnh(accessed 9 July 2010)
33. National Institute for Health and Clinical Excellence (2006) Obesity guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. http://guidance.nice.org.uk/ CG43(accessed 9 July 2010)
34. Papakonstantinou E, Triantafillidou D, Panagiotakos D et al (2010) A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorierestricted obese individuals with newlydiagnosed type 2 diabetes. Eur J Clin Nutr 64: 595-602
35. Pittas AG, Joseph N, Greenberg A (2004) Adipokines and insulin resistance. J Clin Endocrinol Metab 89(2): 447-452
36. Soodini G, Hamdy O (2006) Pathophysiology of diabetes in obesity. In: Mantzoros C. ed, Contemporary Diabetes: Obesity and Diabetes. Humana Press, New Jersey
37. Truby H, Baic S, deLooy A et al (2006) Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials". BMJ 332(7553): 1309-1314
38. UK Prospective Diabetes Study Group (1998) Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131): 837-853
39. Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric acid calculous disease. Am J Clin Nutr 4: 20-24
40. Wei M, Gaskill S, Haffner S, Stern M (1997) Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. Obes Res 5(1): 16-23
41. Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante W (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12): 1796-1808
42. World Health Organization (2005) Obesity and overweight. http://tinyurl.com/a8h6p (accessed 9 July 2010)
43. Wilding J (2009) Pharmacological approaches for treating obesity. In: Williams G, Frühbeck G. eds, Obesity: Science to Practice. Wiley-Blackwell, West Sussex